Market Overview

Afternoon Market Gainers

Related CTB
Robust Auto Sales: 3 Stocks Driving Up - Analyst Blog
Using the Price to Cash Flow to Find Value - Screen of the Week
Related GIMO
Stocks Hitting 52-Week Lows
Morning Market Losers
Tech IPO Stocks Lose Luster (Fox Business)

Cooper Tire & Rubber (NYSE: CTB) skyrocketed 40.55 percent to $34.51 after India's Apollo Tyres announced its plans to acquire the company for $2.5 billion.

GIGAMON (NYSE: GIMO) traded up 35 percent to $25.65 after the company announced Wednesday the pricing of its initial public offering of 6,750,000 shares of its common stock at a price to the public of $19.00 per share.

SGOCO Group (NASDAQ: SGOC) jumped 26.09 percent to $2.90 on Q1 revenue result.

Ulta Salon, Cosmetics & Fragrance (NASDAQ: ULTA) popped 17.06 percent to $98.64 on upbeat quarterly earnings report.

Spectra Energy (NYSE: SE) shot up 9.99 percent to $33.35 after Morgan Stanley and Deutsche Bank upgraded the company to Buy rating.

Health Management Associates (NYSE: HMA) surged 8.68 percent to $15.14 after a morning of high-volume trading. The Florida based hospital operators agreed to lease the Munroe Regional Medical Center in association with the University of Florida Health Shands Hospital.

UQM Technologies (NYSE: UQM) jumped 9.02 percent to $1.45 after the company signed a new long-term supply agreement with Electric Vehicles International.

National Bank of Greece  (NYSE: NBG) popped 7.31 percent to $5.50 on news that Greece had deposit in flows in May and June.

Albany Molecular Research (NASDAQ: AMRI) surged 8.11 percent to $11.73 on positive valuations from Sterne Agee.

Questcor Pharmaceuticals (NASDAQ: QCOR) jumped 8.25 percent to $45.59 after the company acquired rights to develop Synacthen®.

Cytokinetics (NASDAQ: CYTK) popped 7.08 percent to $1.36 on news that the company will receive $25 million plus potential milestone payments and royalties.

Posted-In: News Economics Markets Movers Reviews

 

Most Popular

Related Articles (AMRI + CTB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free